Correction to: Multicenter study of lumen-apposing metal stents with or without pigtail in endoscopic ultrasound-guided biliary drainage for malignant obstruction—BAMPI TRIAL: an open-label, randomized controlled trial protocol

García-Sumalla, Albert; Loras, Carme; Sánchiz, Vicente; Sanz, Rafael Pedraza; Vázquez-Sequeiros, Enrique; Aparicio, José Ramón; Serna-Higuera, Carlos de la; Luna-Rodriguez, Daniel; Andújar, Xavier; Capilla, Mercedes Ramón; Barberá, Tatiana; Foruny-Olcina, Jose Ramon; Martínez, Belén; Durà, Miguel; Salord, Silvia; Laquente, Berta; Tebé, Cristian; Videla, Sebastià; Pérez-Miranda, Manuel; Gornals, Joan B.

doi:10.1186/s13063-022-06138-7

Cited by 2 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, a retrospective study on 41 patients did not find any potential advantages [17]. An ongoing open-label multicenter randomized controlled trial (RCT), the BAMPI study, conducted in three experienced centers in Spain will provide a definitive answer to this important issue [18]. Another specific entity is the sump syndrome, in which refluxed duodenal contents, calculi or debris occlude the stent lumen in the portion of the CBD distal to the placed stent, leading to biliary and/or pancreatic AEs such as ascending cholangitis [19].…”

Section: Endoscopic Ultrasound-guided Choledochoduodenostomymentioning

confidence: 99%

Endoscopic Ultrasound Biliary Drainage in Pancreatic Cancer

Lau,

Rimbaș,

Tripodi

et al. 2023

JGLD

View full text Add to dashboard Cite

Endoscopic ultrasound (EUS) guided biliary drainage (BD) is an accepted salvage procedure in patients with distal malignant biliary obstruction (DMBO) when endoscopic retrograde cholangiopancreatography (ERCP) is unsuccessful. The potential advantages of EUS-BD include gastric or duodenal biliary access, utilization of novel biliary stents and stent placement away from the area of stenosis, resulting in longer stent patency. These features make EUS-BD very appealing as a primary procedure for biliary drainage. There is a growing body of evidence supporting the utilization of EUS as a primary drainage procedure instead of ERCP, with comparable outcomes.

show abstract

Section: Endoscopic Ultrasound-guided Choledochoduodenostomymentioning

confidence: 99%

Endoscopic Ultrasound Biliary Drainage in Pancreatic Cancer

Lau,

Rimbaș,

Tripodi

et al. 2023

JGLD

View full text Add to dashboard Cite

show abstract

“…42,43 A large multicenter randomized controlled trial is underway to answer this question better. 44 A coaxial plastic stent may be placed in EUS-CDS, depending on the endoscopist's discretion.…”

Section: Recommendationmentioning

confidence: 99%

Society of Gastrointestinal Endoscopy of India Consensus Guidelines on Endoscopic Ultrasound-Guided Biliary Drainage: Part II (Technical Aspects)

Samanta

Udawat

Chowdhary

et al. 2023

Journal of Digestive Endoscopy

View full text Add to dashboard Cite

Endoscopic management of bile duct obstruction is a key aspect in gastroenterology practice and has evolved since the first description of biliary cannulation by McCune et al in 1968. Over many decades, the techniques and accessories have been refined, and currently, the first-line management for extrahepatic biliary obstruction is endoscopic retrograde cholangiopancreatography (ERCP). However, even in expert hands, the success rate of ERCP reaches up to 95%. In almost 4 to 16% cases, failure to cannulate the bile duct may necessitate other alternatives such as surgical bypass or, more commonly, percutaneous transhepatic biliary drainage (PTBD). While surgery is associated with high morbidity and mortality, PTBD has a very high reintervention and complication rate (∼80%) and poor quality of life. Almost parallelly, endoscopic ultrasound (EUS) has come a long way from a mere diagnostic tool to a substantial therapeutic option in various pancreaticobiliary diseases. Biliary drainage using EUS-guidance (EUS-BD) has gained momentum since the first report published by Giovannini et al in 2001. The concept of accessing the bile duct through a different route than the papilla, circumventing the shortcomings of PTBD, and sometimes bypassing the actual obstruction have enthused a lot of interest in this novel strategy. The three key methods of EUS-BD entail transluminal, antegrade, and rendezvous approach. Over the past decade, with growing experience, EUS-BD has been found to be equivalent to ERCP or PTBD for malignant obstruction with better success rates. EUS-BD, however, is not devoid of adverse events and can carry fatal adverse events. However, neither the technique of EUS-BD nor the accessories and stents for EUS-BD have been standardized. Additionally, different countries and regions have different availability of the accessories, making generalizability a difficult task. Thus, technical aspects of this evolving therapy need to be outlined. For these reasons, Society of Gastrointestinal Endoscopy of India (SGEI) deemed it appropriate to develop technical consensus statements for performing safe and successful EUS-BD.

show abstract

Correction to: Multicenter study of lumen-apposing metal stents with or without pigtail in endoscopic ultrasound-guided biliary drainage for malignant obstruction—BAMPI TRIAL: an open-label, randomized controlled trial protocol

Abstract: Following the publication of the original article [1], we were notified that the below statement needed to be added to the Acknowledgements section:'We thank CERCA Programme / Generalitat de Catalunya for institutional support'.The original article has been corrected.

Cited by 2 publications

References 1 publication

Endoscopic Ultrasound Biliary Drainage in Pancreatic Cancer

Endoscopic Ultrasound Biliary Drainage in Pancreatic Cancer

Society of Gastrointestinal Endoscopy of India Consensus Guidelines on Endoscopic Ultrasound-Guided Biliary Drainage: Part II (Technical Aspects)

Contact Info

Product

Resources

About